← Leaderboards
Brian Iskra
University Of Texas Hlth Science Center
$187,876
Attributed
$187,876
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $44.9K · FY2017–21$50K$37.5K$25K$12.5K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$187,876 · 1
By mechanism
F30$187,876 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- David Gius$12,824,808
- Peter J Houghton$32,798,876
- Gregory J. Aune$387,601
Others in their field
Other Emerging Leaders on “Clinical Phenotype”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Leonard Freedman · Leidos Biomedical Research, Inc.$47,509,521
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$24,621,503
- Badri N Vardarajan · University Of Miami School Of Medicine$22,034,688
- James Dale Berry · Brigham And Women'S Hospital$20,303,231
Research focus
Clinical PhenotypeAdultAdipocytesAffectAge GroupAge RelatedAgingAdipose TissueBioenergeticsBiologyBody SystemBone MarrowCancer SurvivorCancer TherapyCardiacCardiovascular SystemBasic ScienceCell InjuryCell TypeCentral ObesityChemotherapyChildhoodChildhood Cancer SurvivorCohort
Grant awards (5)
Targeting Doxorubicin-Induced Mitochondrial Failure in Mesenchymal Stem Cells with Metformin$44,858
F30 · FY2021 · AG · contact PI
Targeting Doxorubicin-Induced Mitochondrial Failure in Mesenchymal Stem Cells with Metformin$43,503
F30 · FY2020 · AG · contact PI
Targeting Doxorubicin-Induced Mitochondrial Failure in Mesenchymal Stem Cells with Metformin$33,888
F30 · FY2019 · AG · contact PI
Targeting Doxorubicin-Induced Mitochondrial Failure in Mesenchymal Stem Cells with Metformin$33,164
F30 · FY2018 · AG · contact PI
Targeting Doxorubicin-Induced Mitochondrial Failure in Mesenchymal Stem Cells with Metformin$32,463
F30 · FY2017 · AG · contact PI